-+ 0.00%
-+ 0.00%
-+ 0.00%

Tronox Shares Slid Even Though Sales Rose

Simply Wall St·11/07/2026 15:30:58
Listen to the news

If you had looked at Tronox on 1 January 2026 and decided to sit it out while analysts argued over price targets as far apart as US$1 and US$7, the choice might feel very different today. Investors who held Tronox from the start of the year are down 40.0%, including dividends. The question is simple and uncomfortable: Which of the early warnings on debt, regulation, or Chinese competition were already on the table then?

On Simply Wall St, a Narrative is an investor's thesis written down: the reasoning, plus the numbers it rests on. Run those numbers and you get an estimated Fair Value.

Tronox has already moved. Pinpoint other ways to investigate the theme among 33 best rare earth metal stocks.

Two Conflicting Stories Tronox Investors Had To Weigh

The shares cost US$4.17 at the start of the period, and Tronox sat between two sharply different stories about what might come next.

In the bullish narrative, a fair value of US$7.38 rested on the idea that cost savings would run ahead of plan, with management aiming for almost double the 2025 target by year end. Supporters also pointed to rare earth minerals as a potential extra profit engine beyond titanium dioxide pigment.

The bearish view argued for a fair value of US$1 and focused on pressure from low cost Chinese rivals and industry overcapacity. It also leaned heavily on Tronox's leverage, with net debt of US$2.9b and a net leverage ratio of 6.1 times seen as a core financial risk.

NYSE:TROX Trailing 12-Month Earnings & Revenue History as at Nov 2026
NYSE:TROX Trailing 12-Month Earnings & Revenue History as at Nov 2026

What The Tronox Results Actually Tested

The rare earths refinery backing of up to A$849 million and Tronox moving ahead on its rare earths program clearly supported the bullish story that talked about a second profit engine. At the same time, Tronox still reported losses in Q1 and Q3 2026, even though revenue and net income both rose in Q3 compared with Q3 2025, so the profitability part of the optimistic case stayed unproven. Overall, the evidence cut both ways.

The key assumption here was that higher volume projects and cost actions would quickly turn Tronox into a consistently profitable business. For any similar stock, track reported net income and net margin against those promises each quarter and compare them with what was implied in the bullish and bearish cases at the decision date.

What You Would Be Paying For In Tronox Today

At a current share price of US$2.51, Tronox trades well below where the selected Narrative's Fair Value sits, based on its own assumptions. The thesis leans on the vertically integrated pigment business and the rare earths projects as twin supports for a recovery story.

For that higher figure to hold, a buyer today would need to see Tronox converting its footprint changes and cost targets into clearly stronger, lasting margins while carrying its debt load.

"The main thing that has to go right is that Tronox converts the current mix of footprint rationalization, cost improvement targets, and working capital release into durable margin recovery, despite higher sulfur and sulfuric acid input costs and its existing debt load."

That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for

Before The Next Story Makes Headlines

Passing on this one could have spared you a loss. Where might you find the opposite surprise? Start looking for companies whose prices leave room for a better outcome than investors expect. These three trade below our estimated value.

  • Company 1 - 29% below our estimate - ties AI workloads, subscriptions and usage-based services onto one expanding cloud foundation.
  • Company 2 - 15% below our estimate - shifts fabrication toward higher value silicon carbide, GaN and embedded power platforms for electrification.
  • Company 3 - 40% below our estimate - relies on AI accelerator racks that customers pair with a tightly integrated software stack for inference.

Three companies from the same screener. Open all 39 potentially undervalued companies →